Loading company…
ID 404999604 · FY 2023–2024 · 2 years
Subsidiary of შეზღუდული პასუხისმგებლობის საზოგადოება ისთჰორნ ქლინიქალ სერვისიზ ინ სიიი ლიმითიდი (100.0%)
კომპანიის ძირითად საქმიანობას წარმოადგენს სამედიცინო კვლევების წარმოება საქართველოში.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2023 | 2024 | CAGR |
|---|---|---|---|
| Total Revenue | 3,169 | 5,706 | +80.1% |
| Total COGS | 0 | 0 | |
| Gross Profit | 3,169 | 5,706 | +80.1% |
| Gross Margin | 100.0% | 100.0% | |
| Total Operating Expenses | -3,377 | -5,359 | +58.7% |
| EBITDA | -208 | 347 | nmf |
| EBITDA Margin | -6.6% | 6.1% | |
| Total D&A | -15 | -45 | +204.9% |
| EBIT / Operating Income | -223 | 301 | nmf |
| Total Other Income | -12 | 107 | nmf |
| Profit Before Tax | -236 | 408 | nmf |
| Total Income Tax | 0 | 0 | |
| Net Profit / (Loss) | -221 | 453 | nmf |
| Net Margin | -7.0% | 7.9% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Ownership & directors from companyinfo.ge (public corporate registry).